Electra Therapeutics Inc. (ETRA) vs Oramed Pharmaceuticals Inc. (ORMP)

A side-by-side comparison of Electra Therapeutics Inc. and Oramed Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ETRA

Electra Therapeutics Inc.

$202M

$9.50HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT

ORMP

Oramed Pharmaceuticals Inc.

$182M

$4.45HealthcareDelayed quote: Oct 6, 2026, 12:13 PM EDT

Total return — ETRA vs ORMP

growth of $100 · dividends reinvested · last 1y

ETRA -26.5% (-26.5%/yr)ORMP -2.6% (-2.6%/yr)ORMP compounded faster over this window

ETRA ORMP

Metrics side by side

Total return (annualized)

Metric	ETRA	ORMP
Total return (1Y)	N/A	98.49%
Total return CAGR (3Y)	N/A	26.68%
Total return CAGR (5Y)	N/A	-25.80%
Total return CAGR (10Y)	N/A	-3.86%

ETRA is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full ETRA analysis Full ORMP analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.